Extract

B1621007 is designed to study the safety and efficacy of PF-04937319 in patients with type 2 diabetes

Inclusion criteria

• Type 2 diabetes mellitus

Country

• Hungary
• India
• Philippines
• Romania
• Slovakia
• South Africa
• Taiwan, Province of China
• United States

Links

• ictrp
• nct